Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Obmira 25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Chemo Healthcare Pvt Ltd

Salt Composition

Mirabegron (25mg)

Overview Obmira 25mg Tablet ER

To alleviate overactive bladder symptoms—including frequent urination, urgency, and incontinence—consider Obmira 25mg Extended-Release Tablets. This medication promotes bladder muscle relaxation, enhancing urine storage capacity. Always adhere to your physician's prescribed dosage and duration; it can be taken with or without food. Swallow the tablet whole—do not crush or chew. Discontinuing Obmira 25mg ER prematurely may worsen symptoms; complete the prescribed course for optimal results. Potential side effects, though not experienced by all, include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any concerning or persistent side effects to your doctor immediately. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular follow-up appointments as directed by their doctor.

Primary Ingredients of Obmira 25mg Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Obmira 25mg Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Obmira 25mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Obmira 25mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While you can consume it with or without food, consistent timing is recommended.

Common Side effects of Obmira 25mg Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Obmira 25mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Obmira 25mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.

How Obmira 25mg Tablet ER works:

Obmira 25mg Extended-Release Tablets contain a beta-3 adrenergic agonist. This medication acts by stimulating bladder beta-3 receptors, leading to relaxation of the detrusor muscle and thus reducing urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Obmira 25mg Extended-Release Tablets with alcohol. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Obmira 25mg Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Obmira 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Extended-release Obmira 25mg tablets typically do not impair driving ability.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the extended-release Obmira 25mg tablet requires careful administration. A modified dosage of Obmira 25mg extended-release tablets may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Obmira 25mg Extended-Release Tablets. Dosage modifications may be necessary; physician consultation is advised. Obmira 25mg Extended-Release Tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Obmira 25mg Tablet ER :

Should you forget to take your Obmira 25mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Obmira 25mg Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Treatment Category Urology
Action Class Beta-3 agonist for bladder control

FAQs on Obmira 25mg Tablet ER

Obmira 25mg Tablet ER's full effects may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4 to 8 weeks, depending on individual response.
Continue taking your Obmira 25mg Tablet ER, even if your symptoms improve. This medication doesn't cure overactive bladder, but manages urgency, frequent urination, and incontinence. Stopping treatment could cause your symptoms to return.
Obmira 25mg Extended-Release tablets shouldn't disrupt your sleep. Consult your doctor about any sleep issues.
Obmira 25mg Tablet ER should not be used in children under 18 years of age, as its safety and efficacy haven't been established in this population.
No, consistent daily use as prescribed is crucial. This medication manages your condition, not cures it. Intermittent use prevents your bladder from adapting fully, hindering effectiveness and causing symptom recurrence.
Obmira 25mg Tablet ER may cause infections of the kidneys, ureters, bladder, or urethra, though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and promptly report any kidney-related adverse effects to their doctor.
Obmira 25mg Tablet ER may raise blood pressure; monitor your blood pressure regularly if you have hypertension. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, even without symptoms. Obmira 25mg Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Obmira 25mg Tablet ER
198
MRP 229
13% off